Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-31,200
Closed -$9.15M 1600
2020
Q4
$9.15M Buy
+31,200
New +$8M 0.07% 239
2013
Q4
Sell
-901,600
Closed -$15.5M 1893
2013
Q3
$15.5M Buy
901,600
+701,600
+351% +$10.4M 0.15% 103
2013
Q2
$2.32M Buy
+200,000
New +$2.29M 0.02% 457

Other funds holding AMED

Jefferies Group's AMED Position: Q1 2021 in Review

Jefferies Group sold out of Amedisys (AMED) in Q1 2021, closing a stake of 7,000 shares — an estimated $2.05M sold.

Jefferies Group first reported a position in AMED in Q2 2013 and held it in 3 quarters. The position peaked at $2.05M in Q4 2020. 388 funds tracked by Wall St. Rank hold AMED as of Q1 2021.

  • Jefferies Group reported no remaining Amedisys position as of Q1 2021 after selling out during the quarter.
  • Jefferies Group sold 7,000 Amedisys shares in Q1 2021, an estimated $2.05M.
  • Jefferies Group first reported a position in Amedisys in Q2 2013 and held it in 3 quarters.
  • Jefferies Group's Amedisys position peaked at $2.05M in Q4 2020.
  • 388 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.

Based on Jefferies Group's 13F filing for Q1 2021, filed 14 May 2021.